Muallam, Rosdy A.
HRN: 26-50-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/19/2025
MUPIROCIN 2%, 15G (TUBE)
01/19/2025
01/25/2025
TOPICAL
Pea Size
Q12
Wound Debridement
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes